Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,590,952
+$5,874,048 QoQ
Shares Held
29,739
0.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
5.25%
of 13F equity value
Holder Rank
#81
of 504 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Artia Global Partners LP holds $407,350,933 across 37 Biotechnology names. ARGX ranks #5 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
516,447 | $68,821,727 | |
| 2 | INSM |
INSMED Inc
|
589,052 | $62,804,724 | |
| 3 | TRVI |
Trevi Therapeutics, Inc.
|
2,210,852 | $41,232,389 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
185,390 | $34,719,839 | |
| 5 | ARGX |
Argenx SE
This page
|
29,739 | $27,590,952 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
339,033 | $19,260,464 | |
| 7 | NAMS |
NewAmsterdam Pharma Co N.V.
|
503,936 | $17,078,391 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
162,990 | $15,888,265 |
All Filings in ARGX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,590,952 | 29,739 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $21,716,904 | 29,739 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $54,408,624 | 64,699 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $57,759,061 | 78,311 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $43,166,589 | 78,311 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,694,585 | 11,311 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,956,265 | 11,311 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,206,007 | 15,138 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,509,945 | 15,138 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $13,480,185 | 34,238 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,025,162 | 34,238 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $24,206,877 | 49,238 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,098,281 | 46,438 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,563,402 | 36,404 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $32,277,831 | 85,204 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||